Careteq (ASX:CTQ) Long-Term Debt: A$0.00 Mil (As of Dec. 2025)


What is Careteq Long-Term Debt?

Careteq ASX:CTQ Long-Term Debt is A$0.00 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

Careteq's Long-Term Debt for the quarter that ended in Dec. 2025 was A$0.00 Mil.

Careteq's quarterly Long-Term Debt increased from Dec. 2024 (A$0.09 Mil) to Jun. 2025 (A$0.65 Mil) but then declined from Jun. 2025 (A$0.65 Mil) to Dec. 2025 (A$0.00 Mil).

Careteq's annual Long-Term Debt declined from Jun. 2023 (A$0.02 Mil) to Jun. 2024 (A$0.01 Mil) but then increased from Jun. 2024 (A$0.01 Mil) to Jun. 2025 (A$0.65 Mil).

Careteq  (ASX:CTQ) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Careteq Long-Term Debt Related Terms

Careteq Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Careteq's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Careteq Long-Term Debt Chart

Careteq Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Long-Term Debt
0.00 0.00 0.02 0.01 0.65

Careteq Semi-Annual Data
Jun21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only 0.17 0.01 0.09 0.65 0.00
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of A$0.00 Mil mean?
Careteq (ASX:CTQ) has a Long-Term Debt of A$0.00 Mil as of Dec. 2025.
Is Careteq's Long-Term Debt too high?
Careteq's current Long-Term Debt is A$0.00 Mil.
How does Careteq's Long-Term Debt compare to VEEV and BTSG?
Careteq's Long-Term Debt of A$0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Careteq's current Long-Term Debt is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Careteq stock overvalued right now?
Based on GuruFocus' analysis, Careteq (ASX:CTQ) is currently considered Modestly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.01 — trading 30% above its estimated fair value. The current Long-Term Debt is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Careteq (ASX:CTQ), the current Long-Term Debt is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Careteq Business Description

Address 99 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
Careteq Ltd provides Residential Medication Management Review and Home Medicines Review services as part of the Medication Management Programs, generating revenue from medication review, education, and support services. The company focuses on medication management and home care solutions to provide continuity of care and improve clinical outcomes for patients through Home Medication Reviews. Medication-related harm includes adverse drug reactions, medication errors, and complications that jeopardise patient safety and increase healthcare costs. The company operates in Australia.